HIV coinfection with hepatitis c pathophysiology: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
| Line 14: | Line 14: | ||
[[Category:Hepatitis|C]] | [[Category:Hepatitis|C]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Latest revision as of 18:01, 18 September 2017
|
HIV coinfection with hepatitis c Microchapters |
|
Differentiating HIV coinfection with hepatitis c from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
HIV coinfection with hepatitis c pathophysiology On the Web |
|
American Roentgen Ray Society Images of HIV coinfection with hepatitis c pathophysiology |
|
HIV coinfection with hepatitis c pathophysiology in the news |
|
Directions to Hospitals Treating HIV coinfection with hepatitis c |
|
Risk calculators and risk factors for HIV coinfection with hepatitis c pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Pathophysiology
HIV’s effect on Hepatitis C: Studies have shown that HIV infection in a person who is also infected with HCV results in higher levels of HCV in the blood, more rapid progression to HCV-related liver disease, and increased risk for cirrhosis and liver cancer. As a result, HCV is now regarded as an opportunistic infection in people with HIV infection, although it is not considered an AIDS-defining illness.
HCV’s effect on HIV: Some research suggests that infection with genotype 1 HCV is associated with more rapid progression to AIDS or death, although this is still controversial. Most people with HCV infection in the U.S. have genotype 1. Genotypes 2 and 3 are more common in Europe. Some evidence also indicates that HCV is associated with impaired CD4+ T cell recovery during antiretroviral therapy.